Could an Old Diabetes Drug Hold the Secret to Slower Aging?

For decades, metformin has been a cornerstone in managing type 2 diabetes, helping millions control blood sugar levels effectively. But now, researchers are looking at it for reasons beyond glucose control—specifically, its potential to slow down aging.

Originally derived from a traditional herbal remedy, metformin doesn’t just regulate insulin. It appears to influence some of the core biological processes tied to aging. By improving insulin sensitivity, reducing chronic inflammation, and supporting the body’s natural cellular cleanup system—called autophagy—metformin touches on several hallmarks of aging at once.

Why does this matter?

Unlike many experimental anti-aging treatments, metformin has a long safety record and is widely available. Its affordability and well-documented profile make it a compelling candidate for further study. The Targeting Aging with Metformin (TAME) trial, currently underway, aims to test whether metformin can delay the onset of age-related diseases like heart disease, cancer, and cognitive decline in non-diabetic adults.

While it’s not yet a go-to anti-aging pill, the growing body of evidence suggests metformin may do more than manage diabetes—it could help us stay healthier longer. That said, experts caution against self-prescribing. The full picture of its long-term effects in healthy individuals is still emerging.

In a world chasing the fountain of youth, sometimes the most promising leads come not from flashy new compounds, but from old, trusted medicines quietly doing more than we first realized. Metformin may well be one of them.

See also

In-depth articles

Related topics